HopeStage
Back to all studies
CompletedNCT00483106

Methylphenidate for ADHD in children

About this titleRead the official source — NCT00483106
Medication studyAges 6–12Canada
The study in practice

Understand this study

Who was this study for?

Listed age limits: 6 years to 12 years.

Listed locations
MontrealSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: November 1999
Recruitment status
Completed
Enrollment listed in the registry
885
Sponsor
McGill University
Sponsor type
University
Study type
Drug
Intervention type
Drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
Canada
Age range
From 6 Years to 12 Years
Official registry ID
NCT00483106
Official title
Show the full official title

Clinical and Pharmacogenetic Study of Attention Deficit With Hyperactivity Disorder (ADHD)

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Montreal

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is McGill University, a university.

Did this study involve medication?

Yes. The study involved medication, including Ritalin and Placebo.

Who was this study for?

Listed age limits: 6 years to 12 years.

Want to explore more studies?

Explore studies